• Fujian Haixi Pharmaceuticals set out its board and committee line-up in a disclosure dated Aug. 4, 2026.
• Executive directors: Chairman Dr. Kang Xinshan, Feng Yan, Dr. Chen Guangming, Li Junqing, Chen Tingze.
• Non-executive director: Xu Dong; independent non-executive directors: Lin Bin, Wang Shanshan, Pu Meiting.
• Committee chairs: Pu Meiting (Audit), Wang Shanshan (Remuneration and Assessment, Nomination), Dr. Kang (Strategy).
• Other committee memberships include Dr. Kang (Remuneration, Nomination), Feng Yan (Strategy), Lin Bin (Audit, Strategy), Pu Meiting (Remuneration, Nomination).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujian Haixi Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260804-12270908), on August 04, 2026, and is solely responsible for the information contained therein.